CarePath key facts
as of Oct 2026- Developer of a patient monitoring technology designed for urologic care at home.
- CarePath is valued at approximately $28.9M as of Oct 2026 (last reported valuation).
- It has raised $19.4M; the latest was Later Stage VC ($340K) in Nov 2025.
- Notable investors include Launch Tennessee, InvestTN, JumpStart Capital, Jumpstart Capital (Tennessee), Laborie Medical Technologies — 7 tracked in total.
- Status: Privately Held (backing).
CarePath's last reported valuation, Nov 2025. Nothing priced has surfaced since.
- ·Watch CarePath: the Monday email on marks, rounds and moves
CarePath funding rounds
No funding rounds for CarePath are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
CarePath valuation
CarePath's last reported valuation was $28.9 million in Nov 2025. No priced round, secondary trade or fund mark has surfaced since.
CarePath investors
7 investors are on record for CarePath, including Launch Tennessee, InvestTN, JumpStart Capital and Jumpstart Capital (Tennessee).
About CarePath
Developer of a patient monitoring technology designed for urologic care at home. The company's technology increases patient compliance and data accuracy, confident and appropriate diagnoses, patient satisfaction and comfort, and decreases overall healthcare costs, enabling patients to get access to a system that provides real-time insights into patient symptoms to find optimal treatment and personalized treatment plans, improves patient satisfaction and comfort, and reduces overall healthcare costs.
- Sector
- Healthcare
- HQ
- Knoxville, TN, United States
- Founded
- 2020
- Employees
- 15
- Website
- carepathurology.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.